<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Inflammatory Biomarkers &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/inflammatory-biomarkers/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 12:04:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Inflammatory Biomarkers &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Novel Biomarker Tool Assesses Inflammatory Risk in Heart Disease</title>
		<link>https://bioengineer.org/novel-biomarker-tool-assesses-inflammatory-risk-in-heart-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 12:03:43 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Based on the content]]></category>
		<category><![CDATA[CABIT]]></category>
		<category><![CDATA[CABIT tool]]></category>
		<category><![CDATA[Cardiovascular risk assessment]]></category>
		<category><![CDATA[here are 5 appropriate tags: **İskemik Kalp Hastalığı]]></category>
		<category><![CDATA[İnflamatuar Biyobelirteçler]]></category>
		<category><![CDATA[Inflammatory Biomarkers]]></category>
		<category><![CDATA[ischemic heart disease]]></category>
		<category><![CDATA[Kişiselleştirilmiş Tıp** **Explanation:** 1. **İskemik Kalp Hastalığı:** The primary disease context of the research and the tool (CABIT). 2. **İn]]></category>
		<category><![CDATA[personalized medicine in cardiology]]></category>
		<category><![CDATA[Risk Değerlendirme]]></category>
		<guid isPermaLink="false">https://bioengineer.org/novel-biomarker-tool-assesses-inflammatory-risk-in-heart-disease/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have developed and validated a novel tool designed to assess inflammatory risk levels associated with ischemic heart disease (IHD). This innovative risk assessment model, known as CABIT, integrates multiple biomarkers to provide a comprehensive analysis of inflammatory status, which is crucial for predicting the likelihood of cardiovascular events. The study, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319761</post-id>	</item>
		<item>
		<title>Rewrite Pediatric congenital heart disease: inflammatory biomarkers mediate the association between preoperative ZlogNT-proBNP and postoperative prolonged ventilation as a headline for a science magazine post, using no more than 8 words</title>
		<link>https://bioengineer.org/rewrite-pediatric-congenital-heart-disease-inflammatory-biomarkers-mediate-the-association-between-preoperative-zlognt-probnp-and-postoperative-prolonged-ventilation-as-a-headline-for-a-science-magaz/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 07 Jan 2026 15:00:20 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Cardiac surgery** * **Pediatric congenital heart disease:** Ana konu ve hasta popülasyonu. * **ZlogNT-proBNP:** Çalışmanın odak noktası olan yeni ve önem]]></category>
		<category><![CDATA[Inflammatory Biomarkers]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket (virgülle ayrılmış): **Pediatric congenital heart disease]]></category>
		<category><![CDATA[Prolonged ventilation]]></category>
		<category><![CDATA[ZlogNT-proBNP]]></category>
		<guid isPermaLink="false">https://bioengineer.org/rewrite-pediatric-congenital-heart-disease-inflammatory-biomarkers-mediate-the-association-between-preoperative-zlognt-probnp-and-postoperative-prolonged-ventilation-as-a-headline-for-a-science-magaz/</guid>

					<description><![CDATA[In a groundbreaking study published in Pediatric Research, scientists have unveiled crucial insights into the predictive dynamics of preoperative biomarkers in children with congenital heart disease (CHD). This pioneering work elucidates the complex interplay between age-adjusted levels of NT-proBNP, an established cardiac biomarker, and the incidence of prolonged mechanical ventilation following cardiac surgery. The revelation [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314486</post-id>	</item>
		<item>
		<title>Monocyte-Lymphocyte Ratio: A Biomarker for Diabetic Neuropathy</title>
		<link>https://bioengineer.org/monocyte-lymphocyte-ratio-a-biomarker-for-diabetic-neuropathy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 26 Dec 2025 22:30:40 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diabetes complications prediction** **Kısaca Seçim Gerekçesi:** 1. **Monocyte-lymphocyte ratio:** Çalışmanın ana odağı olan biyobelirteç. 2.]]></category>
		<category><![CDATA[Diabetic peripheral neuropathy]]></category>
		<category><![CDATA[Inflammatory Biomarkers]]></category>
		<category><![CDATA[Makalenin içeriği ve anahtar kelimeleri dikkate alınarak en uygun 5 etiket: **Monocyte-lymphocyte ratio]]></category>
		<category><![CDATA[Type 2 diabetes biomarkers]]></category>
		<guid isPermaLink="false">https://bioengineer.org/monocyte-lymphocyte-ratio-a-biomarker-for-diabetic-neuropathy/</guid>

					<description><![CDATA[Research in the realm of diabetes has consistently illuminated the complex interplay between various cellular components of the immune system and the pathophysiology of diabetic complications. A recent study published in BMC Endocrine Disorders dives deep into the role of the monocyte-to-lymphocyte ratio (MLR) as a predictive inflammatory biomarker in patients suffering from type 2 [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">311596</post-id>	</item>
		<item>
		<title>Endocan Levels Surge in Hyperprolactinemia Patients</title>
		<link>https://bioengineer.org/endocan-levels-surge-in-hyperprolactinemia-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 30 Nov 2025 13:57:48 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Endocan]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[Hyperprolactinemia]]></category>
		<category><![CDATA[Inflammatory Biomarkers]]></category>
		<guid isPermaLink="false">https://bioengineer.org/endocan-levels-surge-in-hyperprolactinemia-patients/</guid>

					<description><![CDATA[In the realm of endocrinology, the intricate interplay between hormones and physiological states continues to be a focal point for research and clinical practice. A recent study led by a team of scientists, including Hacıömeroğlu, Güngüneş, and Yalçın, has turned its eye towards hyperprolactinemia, a condition characterized by elevated levels of prolactin in the bloodstream. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">303637</post-id>	</item>
	</channel>
</rss>
